Profile picture

Doctor Kazuhisa Kaneda

Kyoto University Graduate School of Medicine, Kyoto (Japan)
Membership: EAPC Member
Follow
Logo ESC

Contributor content

The influence of age on feasibility and efficacy of online intensive cardiac rehabilitation program for Japanese patients with coronary artery disease.
Presentation
The influence of age on feasibility and efficacy of online intensive cardiac rehabilitation program for Japanese patients with coronary artery disease.
The sustained efficacy of online intensive cardiac rehabilitation program for Japanese patients with coronary artery disease - 6-month follow-up data analysis from the J-ICR pilot study
Presentation
The sustained efficacy of online intensive cardiac rehabilitation program for Japanese patients with coronary artery disease - 6-month follow-up data analysis from the J-ICR pilot study
The influence of concomitant antiplatelet therapy in venous thromboembolism patients treated with anticoagulants in the DOAC era: insight from the COMMAND VTE Registry-2
Presentation
The influence of concomitant antiplatelet therapy in venous thromboembolism patients treated with anticoagulants in the DOAC era: insight from the COMMAND VTE Registry-2
Efficacy of online japanese intensive cardiac rehabilitation for secondary prevention for coronary artery disease: a comprehensive program including exercise, nutrition, mindfulness, and group support
Presentation
Efficacy of online japanese intensive cardiac rehabilitation for secondary prevention for coronary artery disease: a comprehensive program including exercise, nutrition, mindfulness, and group support
Clinical features and long-term outcomes of venous thromboembolism in the warfarin era versus in the direct oral anticoagulant era
Presentation
Clinical features and long-term outcomes of venous thromboembolism in the warfarin era versus in the direct oral anticoagulant era
Clinical characteristics and outcomes of super-low-dose edoxaban of 15 mg in patients with acute venous thromboembolism: insight from the COMMAND VTE Registry-2
Presentation
Clinical characteristics and outcomes of super-low-dose edoxaban of 15 mg in patients with acute venous thromboembolism: insight from the COMMAND VTE Registry-2

ESC 365 is supported by